Gan & Lee Pharmaceuticals. (SHA:603087)
China flag China · Delayed Price · Currency is CNY
58.96
-0.15 (-0.25%)
Mar 26, 2026, 11:29 AM CST

SHA:603087 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
35,18226,33231,06618,42939,49974,247
Market Cap Growth
28.21%-15.24%68.57%-53.34%-46.80%-
Enterprise Value
32,01921,26826,91813,46334,93570,382
Last Close Price
59.1143.3550.9831.5567.67126.80
PE Ratio
37.5642.8491.35-27.1960.33
Forward PE
28.8311.4011.4011.4025.8150.01
PS Ratio
9.148.6511.9110.7610.9422.09
PB Ratio
3.122.382.891.923.898.31
P/TBV Ratio
3.192.442.971.984.008.54
P/FCF Ratio
-272.84--102.30112.63
P/OCF Ratio
63.5149.01283.8362.1236.6459.81
EV/Sales Ratio
8.326.9810.327.869.6720.94
EV/EBITDA Ratio
31.5938.9867.16-22.2444.70
EV/EBIT Ratio
43.3572.20149.52-25.1349.75
EV/FCF Ratio
-145.56220.38--90.48106.77
Debt / Equity Ratio
000.000.000.00-
Debt / EBITDA Ratio
0.000.010.02-0.01-
Debt / FCF Ratio
-0.05--0.05-
Net Debt / Equity Ratio
-0.28-0.22-0.45-0.49-0.51-0.51
Net Debt / EBITDA Ratio
-3.12-4.40-12.099.82-3.30-2.89
Net Debt / FCF Ratio
14.38-24.8510.926.86-13.44-6.91
Asset Turnover
0.320.260.230.160.360.43
Inventory Turnover
0.880.810.960.680.700.64
Quick Ratio
5.403.316.776.0512.6513.14
Current Ratio
7.204.737.996.9714.1514.54
Return on Equity (ROE)
8.23%5.64%3.35%-4.45%15.21%17.08%
Return on Assets (ROA)
3.79%1.55%1.01%-3.94%8.54%11.39%
Return on Invested Capital (ROIC)
8.18%3.95%3.34%-13.72%25.40%29.71%
Return on Capital Employed (ROCE)
6.40%2.60%1.60%-6.90%13.40%15.60%
Earnings Yield
2.63%2.33%1.09%-2.38%3.68%1.66%
FCF Yield
-0.63%0.37%-1.43%-3.73%0.98%0.89%
Dividend Yield
2.61%3.46%0.39%-0.44%0.32%
Payout Ratio
63.54%68.42%--15.46%16.30%
Buyback Yield / Dilution
0.16%-4.28%-0.58%-0.46%-5.28%-5.43%
Total Shareholder Return
2.77%-0.82%-0.19%-0.46%-4.84%-5.12%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.